Delivery Order SPE2DB22D2006-SPE2DB24FV9TY
Award Date 4/24/24
Potential Completion Date 4/25/24
Potential Value $76K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 1,200,000 units of Bicillin L-A, a 2ML pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed-price contract has a ceiling value of $5,705.35 and an ultimate completion date of May 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, for a ceiling value of $2,166.66. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and has a firm fixed price pricing type. The contract does not have a set-aside designation and is a delivery order issued under Amerisourcebergen's existing...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic, to the Defense Logistics Agency (DLA). The $2,102.56 firm-fixed-price delivery order has an ultimate completion date of April 29, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 1,200,000 units (2 ml) of the medication Bicillin L-A. The $54,061.50 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 24, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, to the U.S. government. The contract is a firm fixed price Delivery Order valued at $1,175.24, with a completion date of May 30, 2024. The awarding agency is the Medical Supply Chain division of the Defense Logistics Agency (DLA), which supports the Department of Defense (DoD) and other government agencies with medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of approximately 1.2 million units of the pharmaceutical product Bicillin L-A (2ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $6,019.11 and a completion date of July 2, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 1,200,000 units of Bicillin L-A 2ML injection, a prescription antibiotic medication, at a total ceiling value of $2,350.50. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), on May 6, 2024, with a completion date of May 7, 2024. The contract was awarded as a delivery order under Amerisourcebergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $27,030.75 Firm Fixed Price delivery order is for 1,200,000 units of the pharmaceutical product Bicillin L-A, 2ML. The contract has a completion date of June 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order valued at $134,759.32 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The order is for 1,200,000 units of the antibiotic medication Bicillin L-A, with a completion date of June 24, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of 1,200,000 units of Bicillin L-A, a medication, to the Defense Logistics Agency (DLA). The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC is the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV9TYDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 1,200,000 units of the prescription medication Bicillin L-A, 2 mL, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $76,391.25, has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 7/26/24, 10:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $76.4k | 4/24/24 |